- Home
- COF vs PFE Comparison
COF vs PFE Comparison
Compare COF & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COF
- PFE
- Stock Information
- Founded
- COF 1988
- PFE 1849
- Country
- COF United States
- PFE United States
- Employees
- COF N/A
- PFE N/A
- Industry
- COF Major Banks
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- COF Finance
- PFE Health Care
- Exchange
- COF Nasdaq
- PFE Nasdaq
- Market Cap
- COF 136.1B
- PFE 142.5B
- IPO Year
- COF 1994
- PFE N/A
- Fundamental
- Price
- COF $221.22
- PFE $25.87
- Analyst Decision
- COF Buy
- PFE Hold
- Analyst Count
- COF 15
- PFE 12
- Target Price
- COF $236.73
- PFE $29.36
- AVG Volume (30 Days)
- COF 3.5M
- PFE 43.9M
- Earning Date
- COF 07-22-2025
- PFE 08-05-2025
- Dividend Yield
- COF 1.08%
- PFE 6.65%
- EPS Growth
- COF N/A
- PFE N/A
- EPS
- COF N/A
- PFE 1.89
- Revenue
- COF $23,773,000,000.00
- PFE $63,833,000,000.00
- Revenue This Year
- COF $94.55
- PFE N/A
- Revenue Next Year
- COF $18.10
- PFE N/A
- P/E Ratio
- COF N/A
- PFE $13.66
- Revenue Growth
- COF N/A
- PFE 13.53
- 52 Week Low
- COF $131.55
- PFE $20.92
- 52 Week High
- COF $232.45
- PFE $30.43
- Technical
- Relative Strength Index (RSI)
- COF 59.54
- PFE 65.14
- Support Level
- COF $209.40
- PFE $24.47
- Resistance Level
- COF $217.20
- PFE $25.30
- Average True Range (ATR)
- COF 5.06
- PFE 0.43
- MACD
- COF 0.28
- PFE 0.15
- Stochastic Oscillator
- COF 91.55
- PFE 89.33
About COF Capital One Financial Corporation
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending. Following the acquisition of Discover in 2025, the firm also has a modest personal loan business, though credit card lending still provides the majority of the bank's revenue.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.